Abstract
Background & aims
We aimed to describe the dose–response relationship between daily step counts and intensity with respect to all–cause mortality among US adults diagnosed with metabolic dysfunction–associated steatotic liver disease (MASLD).
Methods
Using data from the National Health and Nutrition Examination Survey (NHANES) database spanning from 2005 to 2006, a cross–sectional study included 1,108 participants was performed to assess the relationship between daily step counts and step intensity with mortality.
Results
A total of 1,108 participants from the NHANES study were included, with a mean age of 49.5 ± 0.9 years. The sample consisted of 533 (48.1%) women, 809(73%) non–Hispanic whites, 122 (10.8%) non–Hispanic blacks, 133 (12.0%) Hispanic, and 44 (4.2%) individuals of other racial backgrounds. Using multivariable–adjusted Cox proportional hazards models, we found that compared to participants in the light–step group, there was significantly lower risk of mortality in the moderate (hazard ratio [HR], 0.47 [95% CI, 0.32–0.69]), high (HR, 0.35 [95% CI, 0.21–0.61]) and vigorous (HR,0.45 [95% CI, 0.22–0.93]) step groups. Sensitivity and subgroup analyses confirmed that the association between step count and mortality remained robust. However, after adjusting for all covariates, greater step intensity was not significantly associated with lower mortality. Further analysis revealed that age, BMI, and self–rated health could have confounded the relationship between step intensity and survival, potentially obscuring any direct effect of step intensity on mortality.
Conclusions
Accumulating a higher number of daily steps, rather than focusing on step intensity, was associated with a lower risk of all–cause mortality in individuals with MASLD. Our findings suggest that achieving 10,000 steps per day may be optimal for reducing the risk of all–cause mortality risk in this population.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer




